Remi Edelstahl (513043)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter generated ₹34 Cr in sales, indicating the company still has an operating base.
• Book value of ₹38.89 per share provides some tangible capital backing, though returns on it are weak.
• ROCE is positive at 7.63%, so existing assets are not completely idle.
• Price at ₹92.88 is below the 52-week low of ₹118.40, so expectations may already be low.

Concerns

• P/E of 80.67 is unjustifiable when latest quarterly net profit is ₹0 Cr and profit growth is -53.01%.
• Sales declined 20.48%, showing a sharp demand or pricing downturn.
• Piotroski F-Score of 3/9 indicates poor financial health and operating fragility.
• No dividend, promoter holding not disclosed, and debt/equity is N/A, leaving major governance and balance-sheet questions unanswered.

AI Analysis

Let me start by saying I don't understand this business well enough to love it. Remi Edelstahl is a small iron and steel products company in India with a market capitalization of just ₹102 Cr. The latest quarter shows ₹34 Cr in sales but net profit of ₹0 Cr. Over the last year, sales fell 20.48% and profits fell 53.01%. At ₹92.88, the stock trades below its own 52-week low of ₹118.40. That is not a bargain; it is a signal that the market has repriced the business downwards. The P/E stands at 80.67, but with earnings this depressed, that ratio is almost meaningless. Book value is ₹38.89, but return on equity is only 4.56%, and return on capital employed is 7.63%. Why would I pay 2.39 times book for a business that earns less on its assets than I could get from a fixed deposit? The Piotroski score of 3 out of 9 is another red flag: it suggests fragile profitability, poor operating efficiency, and a weak balance sheet. There is no dividend to wait for, and promoter holding and debt figures are not disclosed, which adds uncertainty. This is a cyclical commodity business, not a franchise. In steel, you need a cost advantage or a protected niche; these numbers show neither. Graham would ask me for a margin of safety. I see none. There is no evidence the company is turning around. I will simply say: not a business I can value, and not a stock I would buy. Patience is better than hoping for a recovery in a company with zero current earnings.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer